Mechanisms of Action and Overview of OKT3

Research output: Contribution to journalArticle

47 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)615-620
Number of pages6
JournalTherapeutic Drug Monitoring
Volume17
Issue number6
StatePublished - 1995

Fingerprint

Muromonab-CD3
Tacrolimus
Immunosuppressive Agents
Monoclonal Antibodies
Clinical Trials

Keywords

  • Clinical trials
  • Fk506
  • Tacrolimus

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health
  • Toxicology

Cite this

Mechanisms of Action and Overview of OKT3. / Norman, Douglas.

In: Therapeutic Drug Monitoring, Vol. 17, No. 6, 1995, p. 615-620.

Research output: Contribution to journalArticle

@article{7951050c2b2d4582bb1cd47471e1848e,
title = "Mechanisms of Action and Overview of OKT3",
keywords = "Clinical trials, Fk506, Tacrolimus",
author = "Douglas Norman",
year = "1995",
language = "English (US)",
volume = "17",
pages = "615--620",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Mechanisms of Action and Overview of OKT3

AU - Norman, Douglas

PY - 1995

Y1 - 1995

KW - Clinical trials

KW - Fk506

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=0028812791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028812791&partnerID=8YFLogxK

M3 - Article

C2 - 8588230

AN - SCOPUS:0028812791

VL - 17

SP - 615

EP - 620

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 6

ER -